Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.45 |
| ▸ | ADA | P00813 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | SLC9A1 | P19634 | 3/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 3/20 | 0.39 |
| ▸ | CNR2 | P34972 | 3/20 | 0.39 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24421919 | 0.89 | MEN1 (0.57) | MEN1HPGDKMT2AHSD17B10ASAH1 | |
| SCHEMBL21917711 | 0.89 | MEN1 (0.57) | MEN1HPGDKMT2AHSD17B10ASAH1 | |
| Hydrochloric Acid SCHEMBL7246926 | 0.88 | MEN1 (0.55) | MEN1HPGDKMT2AHSD17B10ASAH1 | |
| SCHEMBL21559595 | 0.85 | ASAH1 (0.51) | MEN1HPGDKMT2AHSD17B10ASAH1 | |
| SCHEMBL4906610 | 0.85 | MEN1 (0.53) | MEN1HPGDKMT2AHSD17B10TDP1 | |
| SCHEMBL7854777 | 0.85 | ASAH1 (0.51) | MEN1HPGDKMT2AHSD17B10ASAH1 | |
| SCHEMBL21388677 | 0.85 | ASAH1 (0.51) | MEN1HPGDKMT2AHSD17B10ASAH1 | |
| SCHEMBL14740043 | 0.84 | MEN1 (0.48) | MEN1HPGDKMT2AHSD17B10ASAH1 | |
| SCHEMBL23940232 | 0.84 | MEN1 (0.48) | MEN1HPGDKMT2AHSD17B10ASAH1 | |
| SCHEMBL22810545 | 0.84 | MEN1 (0.48) | MEN1HPGDKMT2AHSD17B10ASAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114787136-A | Substituted benzimidazole carboxamides and their use in the treatment of medical disorders | 比亚尔R&D投资股份公司 | 2022-07-22 | — | — | CN | disclosed |
| US-20190262371-A1 | METHODS AND COMPOSITION FOR THE TREATMENT OF RNA VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190262371-A1 | METHODS AND COMPOSITION FOR THE TREATMENT OF RNA VIRAL INFECTIONS | POLRMT, EIF2AK2, NSUN3 | MEN1 4786/4885HPGD 4689/4885KMT2A 2961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.